MONDAY, July 17, 2023 (HealthDay Now) — Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States…
You may also like
Boston Scientific Recalls Accolade Pacemaker Devices
Listeria Outbreak From Frozen Shakes Kills 12, Sickens...
Most Americans Don’t Know These Heart Disease Risks...
Study Finds No Spike in Cardiac Arrest in Athletes...
Breast Cancer A Killer In Poor Countries, Report Says
More ER Docs Prescribing Meds To Fight Opioid Addiction
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.